
The BMJ has retracted a paper on stem cell therapy for heart failure after sleuths flagged the work for “serious” inconsistencies in data.
Published in October, the paper reported the results of a phase III clinical trial of more than 400 patients in Shiraz, Iran, looking at whether stem cell therapy lowers the risk of heart failure after a heart attack. The journal announced the results in a press release, and news of the findings appeared in several outlets. New Scientist called the study the “strongest evidence yet that stem cells can help the heart repair itself.”
A week after the study was published, sleuths took to PubPeer to point out inconsistencies between the data reported in the article and the dataset uploaded with it. The concerns included a “curious repeating pattern” of records in the dataset and a high number of integers for the height and weight of patients.
Continue reading BMJ retracts cardiac stem cell paper, removes authors months after sleuths flag data ‘mismatch’







